Table 7.62Global assessment in thumb OA

Thumb (CMC)
Global assessment outcomeReferenceInterventionAssessment timeOutcome/effect size
Physician’s global assessment1 RCT (Meenagh et al. 2004) (N=40)Triamcinolone vs placebo12 weeks and 24 weeks post-injection12 weeks: 0.5 (CS) and 2.3 (placebo)
24 weeks: 1.5 (CS) and 5.0 (placebo)
Patient’s global assessment1 RCT (Meenagh et al. 2004) (N=40)Triamcinolone vs placebo12 weeks and 24 weeks post-injection12 weeks: 0.0 (CS) and 2.3 (placebo)
24 weeks: 1.0 (CS) and 5.0 (placebo)

From: 7, Pharmacological management of osteoarthritis

Cover of Osteoarthritis
Osteoarthritis: National Clinical Guideline for Care and Management in Adults.
NICE Clinical Guidelines, No. 59.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.